President Trump has announced a significant executive order (EO) aimed at reducing prescription drug prices by 30-80%, a move that has garnered attention on social media. This announcement follows a teaser about his most crucial post on Truth Social. Trump’s initiative targets the influence of Big Pharma in Washington, which has been criticized for allowing price gouging. The EO, set to be signed on Monday morning, promises to alleviate the financial burden on consumers, making essential medications more accessible. Stay informed on this breaking news and its implications for healthcare affordability.

BREAKING: Just a few hours after teasing his most important Truth Social Post ever, President Trump announced that he’ll be signing an EO Monday morning to lower the cost of prescription drugs 30-80%. Big Pharma’s lobbying of Washington DC has long allowed them to price gouge… pic.twitter.com/LNIdILwoim

— Charlie Kirk (@charliekirk11) May 11, 2025

BREAKING: Just a few hours after teasing his most important Truth Social Post ever, President Trump announced that he’ll be signing an EO Monday morning to lower the cost of prescription drugs 30-80%.

In a surprise announcement that has sent shockwaves through the healthcare industry, President Trump revealed plans to sign an Executive Order aimed at dramatically reducing prescription drug prices. This move, which promises to lower costs by a staggering 30-80%, comes as a response to the long-standing issue of price gouging by Big Pharma. Many are breathing a sigh of relief, hoping this will ease the financial burden on families and individuals struggling to afford necessary medications.

Big Pharma’s lobbying of Washington DC has long allowed them to price gouge.

For years, the pharmaceutical industry has faced criticism for its aggressive lobbying efforts in Washington D.C. These efforts often result in policies that prioritize corporate profits over patient needs. As a result, many Americans find themselves paying exorbitant prices for life-saving medications. The new Executive Order is seen as a direct challenge to this status quo, aiming to hold Big Pharma accountable for their pricing practices.

The Implications of the Executive Order

So, what does this Executive Order mean for you? If successful, it could lead to significant savings on prescription drugs for millions of Americans. This initiative aligns with Trump’s broader healthcare strategy, which aims to increase competition in the pharmaceutical market. The hope is that by lowering prices, more people will have access to the medications they need without sacrificing their financial stability.

Public Reaction to the Announcement

The announcement has sparked a wave of reactions across social media platforms. Supporters are praising the move as a bold step towards healthcare reform, while critics question its feasibility and long-term effects. Many are eager to see how this plan will be implemented and whether it can truly deliver on its promises. The conversation is alive, with people sharing their thoughts and experiences regarding the high costs of prescription drugs.

What’s Next?

As the signing date approaches, all eyes will be on the specifics of the Executive Order. Will it include measures to regulate drug prices more strictly, or will it focus on creating more transparency in pricing? These details will be crucial in determining the effectiveness of the initiative. As the healthcare landscape continues to evolve, it’s essential for consumers to stay informed about changes that could impact their health and finances.

Stay Updated

This development represents a critical moment in the ongoing fight for affordable healthcare. It’s a reminder of the power of advocacy and the importance of holding industries accountable. Keep an eye on the news and updates regarding the Executive Order, as this could be a turning point for many Americans facing high drug costs. For more insights, check out the exciting coverage on [Charlie Kirk’s Twitter](https://twitter.com/charliekirk11/status/1921694887973659008?ref_src=twsrc%5Etfw) for firsthand updates and reactions.

This initiative could pave the way for significant changes in how prescription drugs are priced and accessed in America. With the signing set for Monday morning, the anticipation is palpable. Will this be the breakthrough that consumers have been waiting for? Only time will tell!